RE:RE:Insider sale....3.7 million shares
More than likely Brian Groch.JMHO. Is he gone yet? I think he had close to 4 million shares.They don't need him now that they are forced to get a partner ( or just probably Ipsen ) to do their front line PH III B study up against BCG, which is what the FDA wants and was the original trial before Endo came along.BCG supply too unreliable and toxic, they need something else. No way is there another clusterfrick refractory trial, it's front line or nothing.
After Consonance et al sell their 108 million shares , partnership will be announced. If it was a sale , these guys would't sell.JMHO
Cheers
13PD